Materiały źródłowe

• #1 How Long Does Alcoholic Hepatitis Last?

  https://www.southjerseyrecovery.com/alcohol-abuse/alcoholic-hepatitis/

  Alcoholic hepatitis is an inflammatory liver injury that progresses if someone doesn’t stop drinking or receive treatment. […] The primary treatment for alcoholic hepatitis is to stop drinking completely. Some people may need an alcohol addiction treatment program to do so. […] However, someone with severe alcoholic hepatitis is at high risk of death and may need treatments that can reduce liver injury and help the liver regenerate. […] Medications to stop inflammation might also help, such as corticosteroids. […] Nutritional support is important in treating alcoholic hepatitis. […] If someone isn’t responsive to steroids or other treatments, they may be considered for a liver transplant, but many programs don’t offer transplants to patients with alcoholic hepatitis.

• #2 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  Treatment for alcoholic hepatitis involves quitting drinking as well as therapies to ease the symptoms of liver damage. […] If you’ve been diagnosed with alcoholic hepatitis, you need to stop drinking alcohol and never drink alcohol again. It’s the only way that might reverse liver damage or keep the disease from getting worse. People who don’t stop drinking are likely to have some life-threatening health problems. […] Treatment might include: Medicines. Counseling. Alcoholics Anonymous or other support groups. Outpatient or live-in treatment program. […] Your healthcare professional might suggest a special diet to fix poor nutrition. […] These might help severe alcoholic hepatitis: Corticosteroids. These medicines might help some people with severe alcoholic hepatitis live longer. However, corticosteroids have serious side effects. They’re not likely to be used if you have failing kidneys, stomach bleeding or an infection.

• #3 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  How is alcohol-induced hepatitis treated? […] Theres no medicine to treat alcohol-induced hepatitis directly. The only effective treatment is to quit drinking. However, its best to quit under medical supervision. Quitting cold turkey can lead to withdrawal symptoms and dangerous side effects. […] Your healthcare provider can offer supportive care while you recover from alcohol withdrawal and refer you to further resources to help treat alcohol use disorder. They can also help treat some of the complications that alcohol use and hepatitis cause. […] Supplemental treatments may include: Nutritional therapy. Both alcohol use and liver damage can cause malnutrition, due to appetite suppression, nausea and a reduced ability to metabolize nutrients. Malnutrition can contribute to poor recovery from these diseases. Your healthcare provider may prescribe dietary changes and nutritional supplements to help you recover, and sometimes appetite stimulants. In severe cases, they may treat you with enteral nutrition (tube feeding) while youre in the hospital.

• #4 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  In most patients with alcoholic hepatitis, the illness is mild. The short-term prognosis is good, and no specific treatment is required. Hospitalization is not always necessary. Alcohol use must be stopped, and care should be taken to ensure good nutrition; providing supplemental vitamins and minerals, including folate and thiamine, is reasonable. Patients who are coagulopathic should receive vitamin K parenterally. Anticipate symptoms of alcohol withdrawal, and manage them appropriately. […] In contrast, patients with severe acute alcoholic hepatitis are at a high risk for early death, at a rate of 50% or greater within 30 days. […] Patients with severe alcoholic hepatitis may benefit over the short term from specific therapies directed toward reducing liver injury, enhancing hepatic regeneration, and suppressing inflammation. Glucocorticosteroids are widely used for this purpose, although their benefits have not been proven unequivocally.

• #5 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  Treatment for alcoholic hepatitis involves quitting drinking as well as therapies to ease the symptoms of liver damage. […] If you’ve been diagnosed with alcoholic hepatitis, you need to stop drinking alcohol and never drink alcohol again. It’s the only way that might reverse liver damage or keep the disease from getting worse. People who don’t stop drinking are likely to have some life-threatening health problems. […] Treatment might include: Medicines. Counseling. Alcoholics Anonymous or other support groups. Outpatient or live-in treatment program. […] Your healthcare professional might suggest a special diet to fix poor nutrition. […] These might help severe alcoholic hepatitis: Corticosteroids. These medicines might help some people with severe alcoholic hepatitis live longer. However, corticosteroids have serious side effects. They’re not likely to be used if you have failing kidneys, stomach bleeding or an infection.

• #6

  https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/treatment/

  Successful treatment for alcohol-related liver disease (ARLD) often depends on whether someone is willing to stop drinking alcohol and make changes to their lifestyle. […] Treatment for ARLD involves stopping drinking alcohol. This is known as abstinence, which can be vital depending on what stage the condition is at. […] If you have a more serious form of ARLD (alcoholic hepatitis or cirrhosis) lifelong abstinence is recommended. […] This is because stopping drinking is the only way to prevent your liver damage getting worse and potentially stop you dying of liver disease. […] Nevertheless, if you have alcohol-related cirrhosis or alcoholic hepatitis and do not stop drinking, no medical or surgical treatment can prevent liver failure. […] Once you have stopped drinking, you may need further treatment to help ensure you do not start drinking again.

• #7 Alcoholic Hepatitis: Causes, Symptoms, and Diagnosis

  https://www.healthline.com/health/alcoholic-hepatitis

  Alcohol use both causes and worsens alcoholic hepatitis, so a diagnosis of alcoholic hepatitis means you may want to consider stopping drinking gradually. Quitting drinking can help reduce symptoms and prevent further damage to your liver. […] In the early stages of the condition, avoiding alcohol may even help reverse liver damage. Once more significant damage has occurred, the changes to your liver may become permanent. […] Even if the damage is too severe to reverse, quitting drinking could prevent further harm to your liver. […] According to 2017 research, people with permanent liver damage due to heavy alcohol use who continued drinking had a 30 percent decrease in survival rate, compared to people who stopped drinking. […] Other treatment options might include: […] Getting support for quitting drinking. If you have an alcohol addiction and need help to stop drinking, talk with your doctor about the different treatment options for addiction. Hospitals and clinic facilities can offer inpatient and outpatient support for alcohol detoxification and recovery.

• #8 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  How is alcohol-induced hepatitis treated? […] Theres no medicine to treat alcohol-induced hepatitis directly. The only effective treatment is to quit drinking. However, its best to quit under medical supervision. Quitting cold turkey can lead to withdrawal symptoms and dangerous side effects. […] Your healthcare provider can offer supportive care while you recover from alcohol withdrawal and refer you to further resources to help treat alcohol use disorder. They can also help treat some of the complications that alcohol use and hepatitis cause. […] Supplemental treatments may include: Nutritional therapy. Both alcohol use and liver damage can cause malnutrition, due to appetite suppression, nausea and a reduced ability to metabolize nutrients. Malnutrition can contribute to poor recovery from these diseases. Your healthcare provider may prescribe dietary changes and nutritional supplements to help you recover, and sometimes appetite stimulants. In severe cases, they may treat you with enteral nutrition (tube feeding) while youre in the hospital.

• #9 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  Cessation of alcohol use is the mainstay of treatment for alcoholic hepatitis. The 2019 American Association for the Study of Liver Diseases (AASLD) alcoholic-associated liver disease guideline states that abstinence should be enjoined on patients with alcoholic hepatitis to improve long-term prognosis. […] In general, alcoholic hepatitis resolves or improves greatly following 6-12 months of alcohol abstinence, and continued improvement may be observed for several years. […] Some studies have suggested that improved energy and protein intake may improve the survival rate in patients with severe alcoholic hepatitis. […] However, according to the 2019 American Association for the Study of Liver Diseases (AASLD) alcohol-associated liver disease guidelines, in patients with severe alcoholic hepatitis (MDF of 32 or above) who have no contraindications to corticosteroid use, consideration should be given to the oral administration of prednisolone (40 mg/day) to improve 28-day mortality.

• #10 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  Treatment for alcoholic hepatitis involves quitting drinking as well as therapies to ease the symptoms of liver damage. […] If you’ve been diagnosed with alcoholic hepatitis, you need to stop drinking alcohol and never drink alcohol again. It’s the only way that might reverse liver damage or keep the disease from getting worse. People who don’t stop drinking are likely to have some life-threatening health problems. […] Treatment might include: Medicines. Counseling. Alcoholics Anonymous or other support groups. Outpatient or live-in treatment program. […] Your healthcare professional might suggest a special diet to fix poor nutrition. […] These might help severe alcoholic hepatitis: Corticosteroids. These medicines might help some people with severe alcoholic hepatitis live longer. However, corticosteroids have serious side effects. They’re not likely to be used if you have failing kidneys, stomach bleeding or an infection.

• #11

  https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/treatment/

  The first treatment usually offered is psychological therapy. […] If psychological therapy alone is not effective, you may also need medicine to help you abstain from alcohol, such as: acamprosate, disulfiram, naltrexone. […] For people with severe alcoholic hepatitis, treatment in hospital may be necessary. […] Specific treatment with corticosteroids may be used to reduce inflammation of the liver in some people with this condition. […] A liver transplant is currently the only way to cure irreversible liver failure.

• #12 Alcoholic hepatitis: Symptoms, causes, risks, and treatment

  https://www.medicalnewstoday.com/articles/313928

  Doctors may recommend alcohol treatment programs for people who find it difficult to cut out alcohol. Programs are available both in and out of hospital settings, depending on the severity of the dependence. […] These programs can help people reduce and eventually stop consuming alcohol. Examples of these programs include: Substance Abuse and Mental Health Services Administration (SAMHSA) provides support and information for those looking for help for themselves or others. […] Alcoholics Anonymous (AA) offers help and support for those seeking to reduce alcohol dependence, with meetings locally around the world. […] The National Institute on Alcohol Abuse and Alcoholism (NIAAA) website can help people locate their nearest treatment program or alcohol cessation specialist.

• #13 Alcoholic liver disease: Symptoms, treatment, and causes

  https://www.medicalnewstoday.com/articles/215638

  Ongoing therapy may then be required to prevent a relapse into drinking alcohol. Medications can also prevent relapse, such as: acamprosate, Vivitrol (naltrexone), Topamax (topiramate), baclofen, disulfiram. […] Doctors may also recommend weight loss and quitting smoking as excess weight and smoking have both demonstrated a role in worsening alcoholic liver disease. Doctors may also recommend taking a daily multivitamin. […] Corticosteroids or pentoxifylline may help reduce inflammation in people with acute alcoholic hepatitis while receiving hospital treatment. […] In people with liver failure, the liver completely ceases to function. This can be an outcome of advanced-stage liver disease and often means that a liver transplant is the only option for prolonged survival. A liver transplant is a complicated procedure that depends on a donors availability.

• #14

  https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/treatment/

  The first treatment usually offered is psychological therapy. […] If psychological therapy alone is not effective, you may also need medicine to help you abstain from alcohol, such as: acamprosate, disulfiram, naltrexone. […] For people with severe alcoholic hepatitis, treatment in hospital may be necessary. […] Specific treatment with corticosteroids may be used to reduce inflammation of the liver in some people with this condition. […] A liver transplant is currently the only way to cure irreversible liver failure.

• #15 Alcoholic liver disease: Symptoms, treatment, and causes

  https://www.medicalnewstoday.com/articles/215638

  Ongoing therapy may then be required to prevent a relapse into drinking alcohol. Medications can also prevent relapse, such as: acamprosate, Vivitrol (naltrexone), Topamax (topiramate), baclofen, disulfiram. […] Doctors may also recommend weight loss and quitting smoking as excess weight and smoking have both demonstrated a role in worsening alcoholic liver disease. Doctors may also recommend taking a daily multivitamin. […] Corticosteroids or pentoxifylline may help reduce inflammation in people with acute alcoholic hepatitis while receiving hospital treatment. […] In people with liver failure, the liver completely ceases to function. This can be an outcome of advanced-stage liver disease and often means that a liver transplant is the only option for prolonged survival. A liver transplant is a complicated procedure that depends on a donors availability.

• #16 UCF Physicians Find Alternative Treatment Option for Alcohol-Related Liver Disease | University of Central Florida News

  https://www.ucf.edu/news/ucf-physicians-find-alternative-treatment-option-for-alcohol-related-liver-disease/

  A commonly prescribed pain reliever could help patients with liver damage from alcohol use disorder, UCF research shows. […] Two UCF-trained physicians who are dedicating their careers to addiction medicine and digestive health are receiving national attention for their discovery that an off-label medicine could help patients with alcohol-related liver disease. […] Raj Shah and Richard Henriquez found that gabapentinoids, a family of drugs used to prevent seizures and commonly used for nerve pain, reduced alcohol withdrawal symptoms and slowed the progressions of liver disease better than another FDA-approved drug for alcohol use disorder. […] The physicians found that a statistically significant 15.8% of patients on Acamprosate advanced to severe liver disease, including scarring, cirrhosis, alcohol hepatitis or liver cancer, compared with 13.4% of the veterans taking gabapentin.

• #17 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #18

  https://www.xiahepublishing.com/2310-8819/JCTH-2016-00006

  Alcohol abstinence is the most important predictor for determining long-term survival in patients with AH. […] Corticosteroids are the current main treatment for severe AH (defined as DF 32, or MELD 21, or presence of hepatic encephalopathy) in patients who do not have any contraindications for steroid treatment. […] A recent Cochrane meta-analysis concluded that, overall, there is no clear evidence that steroids are effective in the management of AH. […] The American Association for the Study of Liver Disease (AASLD) guidelines recommend the use of PTX for severe AH if there are contraindications to corticosteroids. […] In the recent study STOPAH (Steroid Or Pentoxifylline for Alcoholic Hepatitis) trial that will be discussed, PTX had no impact on survival compared to placebo in the treatment of severe AH.

• #19 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #20 Alcoholic Hepatitis – EMCrit Project

  https://emcrit.org/ibcc/alcoholic-hepatitis/

  The management of both conditions is overall extremely similar (below), consisting primarily of supportive care. […] The only major difference between the acute management of alcoholic hepatitis versus cirrhosis is the use of steroid. The benefit of steroid in alcoholic hepatitis is controversial, so when in doubt omission of steroid may often be reasonable. […] Steroid is somewhat controversial, but it is generally recommended for more severe disease. […] The largest RCT (the STOPAH trial) didn’t find benefit from steroid in the primary analysis, but rather only detected a 28-day mortality benefit after multivariate, post-hoc analysis. […] Steroid is generally indicated in patients with Maddrey’s Discriminant Function 32 (calculated using MDCalc). […] The usual dose is 40 mg/day of prednisolone (or 32 mg/day of methylprednisolone IV, for patients unable to take oral medications). […] The Lille score should be used after 4-7 days to determine whether the patient is responding to steroid. A score of 0.45 or greater suggests lack of benefit from steroid, implying that steroid may be discontinued.

• #21 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In an attempt to resolve the controversy regarding the use of steroids or pentoxifylline, a double blind, factorial 22, multicenter trial was conducted in the United Kingdom between 2011 and 2014 in patients with a diagnosis of AH (the Steroids or Pentoxifylline for Alcoholic Hepatitis [STOPAH] trial). This study reported a borderline reduction in mortality at 28 days for patients given prednisolone 40 mg daily for 28 days compared with control patients. However, survival curves converged after 28 days such that prednisolone therapy provided no benefit to patients after 90 days or 1 year. […] A number of trials have attempted to assess the therapeutic value of nutritional supplementation using either enteral or parenteral routes. […] A meta-analysis of 9 trials of enteral feeding and 4 trials of parenteral nutrition found that these approaches produce a modest (20%) reduction in mortality.

• #22 Current Management and Future Treatment of Alcoholic Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/april-2020/current-management-and-future-treatment-of-alcoholic-hepatitis/

  Glucocorticoids were first used to treat AH almost 50 years ago, primarily because of the inflammatory features of the illness. […] The 1989 US multicenter trial of methylprednisolone vs placebo for the treatment of severe AH reported a significantly lower 28-day mortality rate in patients treated with methylprednisolone compared with standard care. […] A network meta-analysis using results from 22 recent trials involving 2621 patients with severe AH showed that treatment with glucocorticoids alone or in combination with PTX or the antioxidant N-acetylcysteine (NAC) reduced 28-day but not 90-day mortality compared to standard care based on moderate-quality evidence. […] The results of these studies collectively were used to formulate the current guidelines of both the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver that recommend glucocorticoid treatment for patients with severe AH without active infections.

• #23 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #24 Alcoholic Hepatitis – EMCrit Project

  https://emcrit.org/ibcc/alcoholic-hepatitis/

  The management of both conditions is overall extremely similar (below), consisting primarily of supportive care. […] The only major difference between the acute management of alcoholic hepatitis versus cirrhosis is the use of steroid. The benefit of steroid in alcoholic hepatitis is controversial, so when in doubt omission of steroid may often be reasonable. […] Steroid is somewhat controversial, but it is generally recommended for more severe disease. […] The largest RCT (the STOPAH trial) didn’t find benefit from steroid in the primary analysis, but rather only detected a 28-day mortality benefit after multivariate, post-hoc analysis. […] Steroid is generally indicated in patients with Maddrey’s Discriminant Function 32 (calculated using MDCalc). […] The usual dose is 40 mg/day of prednisolone (or 32 mg/day of methylprednisolone IV, for patients unable to take oral medications). […] The Lille score should be used after 4-7 days to determine whether the patient is responding to steroid. A score of 0.45 or greater suggests lack of benefit from steroid, implying that steroid may be discontinued.

• #25 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #26 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  In most patients with alcoholic hepatitis, the illness is mild. The short-term prognosis is good, and no specific treatment is required. Hospitalization is not always necessary. Alcohol use must be stopped, and care should be taken to ensure good nutrition; providing supplemental vitamins and minerals, including folate and thiamine, is reasonable. Patients who are coagulopathic should receive vitamin K parenterally. Anticipate symptoms of alcohol withdrawal, and manage them appropriately. […] In contrast, patients with severe acute alcoholic hepatitis are at a high risk for early death, at a rate of 50% or greater within 30 days. […] Patients with severe alcoholic hepatitis may benefit over the short term from specific therapies directed toward reducing liver injury, enhancing hepatic regeneration, and suppressing inflammation. Glucocorticosteroids are widely used for this purpose, although their benefits have not been proven unequivocally.

• #27 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #28 Alcoholic hepatitis: Prognosis and treatment | Gastroenterología y Hepatología

  https://www.elsevier.es/es-revista-gastroenterologia-hepatologia-14-articulo-alcoholic-hepatitis-prognosis-treatment-S0210570514000466

  Pentoxifylline is a phosphodiesterase inhibitor that blocks transcription of TNF-. […] It can be used to treat patients with severe AH who cannot tolerate corticosteroids. […] Nutrition is recommended in patients with AH. […] A recent study has assessed the feasibility of performing liver transplantation to highly selected patients with AH that did not respond to corticosteroids. […] Cessation of the alcohol misuse is of paramount importance in the management of patient with AH. […] Behavioral therapy must be a central component of alcoholism treatment.

• #29 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. Patients with a MDF greater than 32, MELD score greater than 20, ABIC score category C, or a Glasgow AH score of 9 predicts higher mortality with a diagnosis of severe AH. Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] For patients unable to take it orally, methylprednisolone, 32 mg intravenously daily, is an option. […] For patients with a Lille score of less than 0.45 (Lille responders), prednisolone should be continued for another three weeks. […] Contraindications to steroid use include any active gastrointestinal (GI) bleeding, severe pancreatitis, uncontrolled diabetes, active infection, or renal failure. Such patients may be managed with pentoxifylline (400 mg orally, three times a day for 28 days).

• #30 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In summary, pentoxifylline appears to increase survival compared with no treatment, but does not increase survival compared with prednisolone. […] NAC (usually given in combination with other oral antioxidants) does not appear to increase survival compared with standard medical therapy. However, the combination of NAC and prednisolone increased 1-month survival, and reduced infections and hepatorenal syndrome, compared with prednisolone alone. […] G-CSF might increase survival of patients with AH. G-CSF is easy to administer and has few adverse effects. However, additional studies should be performed in the West, and G-CSF should be tested in combination with prednisolone before it can be recommended as a treatment for AH. […] The application of these findings therefore requires consideration of each case individually, based on clinical, patient, and physician factors. Finally, no regimen increased the proportion of patients surviving until 6 months.

• #31 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  Corticosteroids seem to improve survival outcomes in patients with severe ASH without specific contraindications such as gastrointestinal bleeding, hepatorenal syndrome (HRS), uncontrolled infection, hepatitis B virus infection, and pancreatitis. […] Pentoxifylline shows an antioxidant effect and weakly inhibits tumor necrosis factor-alpha (TNF-) synthesis. In patients with severe ASH receiving pentoxifylline, a 6-mo survival rate was higher than in those treated with placebo. However, this beneficial effect was challenged by two recent meta-analyses demonstrating that pentoxifylline decreased the risk of fatal HRS but did not improve survival significantly, although it remains inconclusive. […] Recently, the combination treatment with N-acetyl cysteine (NAC), an antioxidant and prednisolone significantly reduced a 1-mo mortality rate compared with prednisolone alone by preventing HRS and infection, although the difference was no longer statistically significant at 3 and 6 mo.

• #32 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In an attempt to resolve the controversy regarding the use of steroids or pentoxifylline, a double blind, factorial 22, multicenter trial was conducted in the United Kingdom between 2011 and 2014 in patients with a diagnosis of AH (the Steroids or Pentoxifylline for Alcoholic Hepatitis [STOPAH] trial). This study reported a borderline reduction in mortality at 28 days for patients given prednisolone 40 mg daily for 28 days compared with control patients. However, survival curves converged after 28 days such that prednisolone therapy provided no benefit to patients after 90 days or 1 year. […] A number of trials have attempted to assess the therapeutic value of nutritional supplementation using either enteral or parenteral routes. […] A meta-analysis of 9 trials of enteral feeding and 4 trials of parenteral nutrition found that these approaches produce a modest (20%) reduction in mortality.

• #33 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In summary, pentoxifylline appears to increase survival compared with no treatment, but does not increase survival compared with prednisolone. […] NAC (usually given in combination with other oral antioxidants) does not appear to increase survival compared with standard medical therapy. However, the combination of NAC and prednisolone increased 1-month survival, and reduced infections and hepatorenal syndrome, compared with prednisolone alone. […] G-CSF might increase survival of patients with AH. G-CSF is easy to administer and has few adverse effects. However, additional studies should be performed in the West, and G-CSF should be tested in combination with prednisolone before it can be recommended as a treatment for AH. […] The application of these findings therefore requires consideration of each case individually, based on clinical, patient, and physician factors. Finally, no regimen increased the proportion of patients surviving until 6 months.

• #34 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  Corticosteroids seem to improve survival outcomes in patients with severe ASH without specific contraindications such as gastrointestinal bleeding, hepatorenal syndrome (HRS), uncontrolled infection, hepatitis B virus infection, and pancreatitis. […] Pentoxifylline shows an antioxidant effect and weakly inhibits tumor necrosis factor-alpha (TNF-) synthesis. In patients with severe ASH receiving pentoxifylline, a 6-mo survival rate was higher than in those treated with placebo. However, this beneficial effect was challenged by two recent meta-analyses demonstrating that pentoxifylline decreased the risk of fatal HRS but did not improve survival significantly, although it remains inconclusive. […] Recently, the combination treatment with N-acetyl cysteine (NAC), an antioxidant and prednisolone significantly reduced a 1-mo mortality rate compared with prednisolone alone by preventing HRS and infection, although the difference was no longer statistically significant at 3 and 6 mo.

• #35 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  The guideline also states that in patients with severe alcoholic hepatitis, 30-day survival may be improved by adding intravenous N-acetylcysteine (NAC) to prednisolone. […] Orthotopic liver transplantation is widely used in patients with end-stage liver disease. […] Patients with alcoholic hepatitis may be informed that their liver injury can be expected to subside, and liver function will improve following at least 6 months of abstinence. […] Adequate nutritional support is of paramount importance for the survival and recovery of patients with alcoholic hepatitis. […] In patients with alcoholic hepatitis who have developed cirrhosis, especially those with coexistent chronic viral hepatitis B or C, consider periodic surveillance for hepatocellular carcinoma. […] The 2019 American Association for the Study of Liver Diseases (AASLD) practice guidance recommends that all patients seen in primary care and gastroenterology/hepatology clinics, as well as all emergency department patients and hospital inpatients be screened for alcohol use using validated questionnaires.

• #36 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In summary, pentoxifylline appears to increase survival compared with no treatment, but does not increase survival compared with prednisolone. […] NAC (usually given in combination with other oral antioxidants) does not appear to increase survival compared with standard medical therapy. However, the combination of NAC and prednisolone increased 1-month survival, and reduced infections and hepatorenal syndrome, compared with prednisolone alone. […] G-CSF might increase survival of patients with AH. G-CSF is easy to administer and has few adverse effects. However, additional studies should be performed in the West, and G-CSF should be tested in combination with prednisolone before it can be recommended as a treatment for AH. […] The application of these findings therefore requires consideration of each case individually, based on clinical, patient, and physician factors. Finally, no regimen increased the proportion of patients surviving until 6 months.

• #37 New treatment options for alcoholic hepatitis

  https://www.wjgnet.com/1007-9327/full/v22/i15/3892.htm

  New treatment options for alcoholic hepatitis. […] Steroids remain the current standard of care in severe alcoholic hepatitis in carefully selected patients. […] No specific treatments are available for those patients who are steroid ineligible, intolerant or unresponsive. […] Modification of gut microbiota composition and their products, such as lipopolysaccharide, nutritional interventions, immune modulation, increasing steroid sensitivity, genetic polymorphism and epigenetic modification of alcohol induced liver damage, augmenting hepatic regeneration using GCSF are potential therapeutic avenues in steroid non-responsive/ineligible patients. […] With better understanding of the pathophysiology, using Omics platforms, newer options for patients with alcoholic hepatitis are expected soon.

• #38 Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial | Annals of Hepatology

  https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-rifaximin-treatment-in-patients-with-S1665268124005325

  Therefore, we aimed to assess the effectiveness of adding rifaximin to corticosteroids or pentoxifylline in SAH patients in this prospective study. […] The primary outcome was survival without liver transplantation at 6 months. Patients who received transplantation were regarded as dead. The secondary outcome was transplantation-free survival at 90 days. […] The results of this pilot study indicate that rifaximin treatment does not improve the prognosis in patients with SAH. Rifaximin treatment was not effective in either the standard treatment group, corticosteroid group, or pentoxifylline group. […] However, studies on rifaximin in SAH, including our study, all had a small number of patients. Therefore, it is necessary to verify the effectiveness of rifaximin through a well-designed RCT that includes more patients in the future. […] In conclusion, adding rifaximin to standard treatment in patients with SAH did not improve short-term LT-free survival and did not prevent the development of liver-related complications.

• #39 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  How is alcohol-induced hepatitis treated? […] Theres no medicine to treat alcohol-induced hepatitis directly. The only effective treatment is to quit drinking. However, its best to quit under medical supervision. Quitting cold turkey can lead to withdrawal symptoms and dangerous side effects. […] Your healthcare provider can offer supportive care while you recover from alcohol withdrawal and refer you to further resources to help treat alcohol use disorder. They can also help treat some of the complications that alcohol use and hepatitis cause. […] Supplemental treatments may include: Nutritional therapy. Both alcohol use and liver damage can cause malnutrition, due to appetite suppression, nausea and a reduced ability to metabolize nutrients. Malnutrition can contribute to poor recovery from these diseases. Your healthcare provider may prescribe dietary changes and nutritional supplements to help you recover, and sometimes appetite stimulants. In severe cases, they may treat you with enteral nutrition (tube feeding) while youre in the hospital.

• #40 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In an attempt to resolve the controversy regarding the use of steroids or pentoxifylline, a double blind, factorial 22, multicenter trial was conducted in the United Kingdom between 2011 and 2014 in patients with a diagnosis of AH (the Steroids or Pentoxifylline for Alcoholic Hepatitis [STOPAH] trial). This study reported a borderline reduction in mortality at 28 days for patients given prednisolone 40 mg daily for 28 days compared with control patients. However, survival curves converged after 28 days such that prednisolone therapy provided no benefit to patients after 90 days or 1 year. […] A number of trials have attempted to assess the therapeutic value of nutritional supplementation using either enteral or parenteral routes. […] A meta-analysis of 9 trials of enteral feeding and 4 trials of parenteral nutrition found that these approaches produce a modest (20%) reduction in mortality.

• #41 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  How is alcohol-induced hepatitis treated? […] Theres no medicine to treat alcohol-induced hepatitis directly. The only effective treatment is to quit drinking. However, its best to quit under medical supervision. Quitting cold turkey can lead to withdrawal symptoms and dangerous side effects. […] Your healthcare provider can offer supportive care while you recover from alcohol withdrawal and refer you to further resources to help treat alcohol use disorder. They can also help treat some of the complications that alcohol use and hepatitis cause. […] Supplemental treatments may include: Nutritional therapy. Both alcohol use and liver damage can cause malnutrition, due to appetite suppression, nausea and a reduced ability to metabolize nutrients. Malnutrition can contribute to poor recovery from these diseases. Your healthcare provider may prescribe dietary changes and nutritional supplements to help you recover, and sometimes appetite stimulants. In severe cases, they may treat you with enteral nutrition (tube feeding) while youre in the hospital.

• #42 Alcoholic Hepatitis: Symptoms, causes, & prevention

  https://recovered.org/alcohol/alcohol-and-health/alcoholic-hepatitis

  Abstinence from alcohol is the largest factor in recovery from alcoholic hepatitis. Quitting alcohol will reduce symptoms of hepatitis, prevent further damage to your liver, and, in the early stages of liver disease, reverse existing damage. […] But even when the damage to your liver is permanent, quitting drinking can preserve the liver function you do have and significantly extend your life. Among heavy drinkers with permanent liver change, those who continued drinking had a 30% lower survival rate than those who quit. […] Treatment for alcoholic hepatitis may also include: nutritional supplementation: heavy drinkers often have protein-calorie malnutrition, which is associated with worse outcomes. Better nutrition, often delivered through tube feeding, can improve their liver function and reduce the likelihood of complications such as infections and encephalopathy. […] medication: this may include corticosteroids, pentoxifylline, N-acetyl cysteine (NAC), and metadoxine […] liver transplant.

• #43 Medical management of severe acute alcoholic hepatitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-severe-acute-alcoholic-hepatitis/

  Best practices for diagnosing and managing severe acute alcoholic hepatitis. […] 1. Abstinence from drinking alcohol is the cornerstone of treatment for alcohol hepatitis (AH). 2. Patients with jaundice and suspected AH should have cultures of blood, urine and ascites, if present, to determine the presence of bacterial infections regardless of whether they have fever. 3. Patients with AH who have jaundice should be admitted to the hospital to encourage abstinence, restore adequate nutrition and exclude serious infections. 4. Imaging of the liver is warranted as part of the evaluation, but caution should be used in administering iodinated contrast dye, as it increases the risk of acute kidney injury (AKI). 5. Patients with AH require a diet with 1-1.5 g protein and 30-40 kcal/kg body weight for adequate recovery. If the patient is unable to eat because of anorexia or altered mental status, a feeding tube should be considered for enteral feeding. Parenteral nutrition alone is inadequate. 6. Severity and prognosis of AH should be evaluated using Maddrey Discriminant Function (MDF), Model for End-Stage Liver Disease (MELD), age, bilirubin, international normalized ratio, and creatinine (ABIC), or Glasgow scoring systems. Current treatments are based on this assessment. 7. Presence of systemic inflammatory response syndrome (SIRS) on admission is associated with an increased risk of multi-organ failure (MOF) syndrome. Development of MOF, usually due to infections developing after initial diagnosis of AH, is associated with a very high mortality rate. 8. Nephrotoxic drugs, including diuretics, should be avoided or used sparingly in patients with AH, since AKI is an early manifestation of MOF. 9. Patients with MDF > 32 or MELD score > 20 without a contraindication to glucocorticoid, such as hepatitis B viral infection, tuberculosis, or other serious infectious diseases, may be treated with methylprednisolone 32 mg daily, but the appropriate duration of treatment remains a subject of controversy. Methylprednisolone does not improve survival beyond 28 days, and the benefits for < 28 days are modest. 10. Patients with a contraindication to glucocorticoids may be treated with pentoxifylline 400 mg three times daily with meals. Data regarding the efficacy are conflicting. 11. Patients with severe AH, particularly those with a MELD score > 26 with good insight into their alcohol use disorder and good social support should be referred for evaluation for liver transplantation, as the 90-day mortality rate is very high. 12. Patients with mild to moderate AH defined by a MELD score < 20 and MDF < 32 should be referred for abstinence counseling and prescribed a high protein diet supplemented with B vitamins and folic acid.

• #44 Treatment of Alcoholic Liver Disease – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2017/treatment-of-alcoholic-liver-disease/

  Cessation of alcohol is necessary to treat alcoholic liver disease. If the patient has simple fatty liver, then cessation will allow the liver to heal and return to normal. If a patient has alcohol-induced fibrosis or cirrhosis and abstains from alcohol, damage to the liver will stop and the liver will get better, although liver scar tissue will remain. In some patients, the fibrosis seems to regress. […] For alcoholic hepatitis or foamy fatty change, stopping alcohol is necessary—and will lead to improvements in most patients—but may not be sufficient to stop the disease. […] Currently, there are no treatments for fatty liver, alcoholic fibrosis, or alcoholic cirrhosis other than abstinence from alcohol. The only disease for which there is specific treatment is alcoholic hepatitis. Researchers have studied corticosteroids and pentoxifylline for many years in patients with alcoholic hepatitis. Most experts recommend prednisolone at a dose of 40 mg a day for 28 or 30 days as the preferred treatment for severe alcoholic hepatitis. Some experts prefer pentoxifylline instead.

• #45 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In an attempt to resolve the controversy regarding the use of steroids or pentoxifylline, a double blind, factorial 22, multicenter trial was conducted in the United Kingdom between 2011 and 2014 in patients with a diagnosis of AH (the Steroids or Pentoxifylline for Alcoholic Hepatitis [STOPAH] trial). This study reported a borderline reduction in mortality at 28 days for patients given prednisolone 40 mg daily for 28 days compared with control patients. However, survival curves converged after 28 days such that prednisolone therapy provided no benefit to patients after 90 days or 1 year. […] A number of trials have attempted to assess the therapeutic value of nutritional supplementation using either enteral or parenteral routes. […] A meta-analysis of 9 trials of enteral feeding and 4 trials of parenteral nutrition found that these approaches produce a modest (20%) reduction in mortality.

• #46 Medical management of severe acute alcoholic hepatitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-severe-acute-alcoholic-hepatitis/

  Best practices for diagnosing and managing severe acute alcoholic hepatitis. […] 1. Abstinence from drinking alcohol is the cornerstone of treatment for alcohol hepatitis (AH). 2. Patients with jaundice and suspected AH should have cultures of blood, urine and ascites, if present, to determine the presence of bacterial infections regardless of whether they have fever. 3. Patients with AH who have jaundice should be admitted to the hospital to encourage abstinence, restore adequate nutrition and exclude serious infections. 4. Imaging of the liver is warranted as part of the evaluation, but caution should be used in administering iodinated contrast dye, as it increases the risk of acute kidney injury (AKI). 5. Patients with AH require a diet with 1-1.5 g protein and 30-40 kcal/kg body weight for adequate recovery. If the patient is unable to eat because of anorexia or altered mental status, a feeding tube should be considered for enteral feeding. Parenteral nutrition alone is inadequate. 6. Severity and prognosis of AH should be evaluated using Maddrey Discriminant Function (MDF), Model for End-Stage Liver Disease (MELD), age, bilirubin, international normalized ratio, and creatinine (ABIC), or Glasgow scoring systems. Current treatments are based on this assessment. 7. Presence of systemic inflammatory response syndrome (SIRS) on admission is associated with an increased risk of multi-organ failure (MOF) syndrome. Development of MOF, usually due to infections developing after initial diagnosis of AH, is associated with a very high mortality rate. 8. Nephrotoxic drugs, including diuretics, should be avoided or used sparingly in patients with AH, since AKI is an early manifestation of MOF. 9. Patients with MDF > 32 or MELD score > 20 without a contraindication to glucocorticoid, such as hepatitis B viral infection, tuberculosis, or other serious infectious diseases, may be treated with methylprednisolone 32 mg daily, but the appropriate duration of treatment remains a subject of controversy. Methylprednisolone does not improve survival beyond 28 days, and the benefits for < 28 days are modest. 10. Patients with a contraindication to glucocorticoids may be treated with pentoxifylline 400 mg three times daily with meals. Data regarding the efficacy are conflicting. 11. Patients with severe AH, particularly those with a MELD score > 26 with good insight into their alcohol use disorder and good social support should be referred for evaluation for liver transplantation, as the 90-day mortality rate is very high. 12. Patients with mild to moderate AH defined by a MELD score < 20 and MDF < 32 should be referred for abstinence counseling and prescribed a high protein diet supplemented with B vitamins and folic acid.

• #47 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  For many people with severe alcoholic hepatitis, the risk of dying is high without a liver transplant. […] But recent studies suggest that well-chosen people with severe alcoholic hepatitis have survival rates after a transplant similar to people with other types of liver disease who get liver transplants.

• #48 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  Liver transplantation is the ultimate treatment for patients with liver failure. Liver transplantation is accepted for patients with alcoholic cirrhosis, and excessive alcohol consumption is a factor in approximately 20% of transplants performed in the United States and in 30%50% of transplants performed in Europe. […] The obvious conclusion that a return to alcohol use after an episode of AH would be harmful was shown decades ago and has been confirmed in recent studies. In the STOPAH trial, drinking alcohol at 90 days after enrollment was the only factor associated with survival at 1 year. It therefore is critical that physicians inform patients of the need to abstain from all alcohol.

• #49 Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation

  https://www.mdpi.com/2075-1729/13/9/1802

  The first data about LT in severe AH was reported by Mathurin et al. in 2011 in a multi-center Franco-Belgian pilot study, which included 26 patients with biopsy-proven AH and no response to steroid therapy. […] Return to alcohol use after LT represents the main concerns for patients with alcohol-related liver disease, especially in the setting of AH where 6 months alcohol withdrawal cannot be guaranteed. […] However, this criterion has been questioned due to the lack of a solid scientific background. […] Return to alcohol use after LT is a complex issue that cannot be assessed as a yes/no variable. […] In conclusion, this review offers a comprehensive analysis of the current literature on severe acute alcohol-related hepatitis considering clinical implications, survival outcomes, and ethical concerns.

• #50 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  The Lille model now allows the early identification of non-responders to steroids, only 25% of whom being alive at 6 mo. Recently, an early LT concept was suggested to those with a first episode of severe ASH not responding to steroids. Explicit improvement of survival was observed in patients who received early LT compared to historical controls without response to steroids.

• #51 Severe alcoholic hepatitis: current perspectives | HMER

  https://www.dovepress.com/severe-alcoholic-hepatitis-current-perspectives-peer-reviewed-fulltext-article-HMER

  The Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial, the largest randomized clinical trial, studied short- and long-term mortality of patients with severe AH. […] A meta-analysis of 22 randomized clinical trials demonstrated improved survival in patients with severe AH treated with steroids and the combination therapy with steroid and N-acetylcysteine was found to have the most benefit in improving short term survival. […] The French-Belgian liver transplant (LT) inclusion criteria for severe AH include those with Lille score 0.45 or worsening liver function one week, without prior episodes of AH, absence of severe coexisting medical or psychiatric conditions, presence of supportive family members, social integration and a lifelong commitment to alcohol abstinence and an absolute consensus among four team circles of medical and paramedical staff prior to listing.

• #52 Severe alcoholic hepatitis: current perspectives | HMER

  https://www.dovepress.com/severe-alcoholic-hepatitis-current-perspectives-peer-reviewed-fulltext-article-HMER

  The Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial, the largest randomized clinical trial, studied short- and long-term mortality of patients with severe AH. […] A meta-analysis of 22 randomized clinical trials demonstrated improved survival in patients with severe AH treated with steroids and the combination therapy with steroid and N-acetylcysteine was found to have the most benefit in improving short term survival. […] The French-Belgian liver transplant (LT) inclusion criteria for severe AH include those with Lille score 0.45 or worsening liver function one week, without prior episodes of AH, absence of severe coexisting medical or psychiatric conditions, presence of supportive family members, social integration and a lifelong commitment to alcohol abstinence and an absolute consensus among four team circles of medical and paramedical staff prior to listing.

• #53 Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation

  https://www.mdpi.com/2075-1729/13/9/1802

  Glucocorticoids are currently the standard of care in AH due to their anti-inflammatory mechanism of action; however, the data are controversial and steroid therapy appears to only partially improve short-term mortality. […] The current European guidelines suggest the initiation of steroid therapy (prednisolone 40 mg/day or methylprednisolone 32 mg/day) in patients with severe AH (mDF ≥ 32 or GAHS ≥ 9) to reduce short-term mortality, emphasizing their ineffectiveness on mid- and long-term survival. […] Adequate nutritional intake should be considered among the goals of medical treatment in patients with severe AH. […] Liver transplantation represents the best therapeutic option for patients with severe acute alcohol-related hepatitis (sAH) who do not respond to medical therapy. […] Although European and American guidelines have recently stated that LT may be considered in highly selected patients who do not respond to medical therapy, policies for early liver transplantation (eLT) in patients with sAH are different among countries.

• #54 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  For many people with severe alcoholic hepatitis, the risk of dying is high without a liver transplant. […] But recent studies suggest that well-chosen people with severe alcoholic hepatitis have survival rates after a transplant similar to people with other types of liver disease who get liver transplants.

• #55 Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation

  https://www.mdpi.com/2075-1729/13/9/1802

  Alcohol-related hepatitis (AH) is a clinical syndrome characterized by recent-onset jaundice in the context of alcohol consumption. […] According to European and American guidelines, liver transplantation (LT) may be considered in highly selected patients who do not respond to medical therapy. […] In conclusion, present data indicate that well-selected patients have excellent outcomes, with survival rates of up to 100% at 24 and 36 months after LT. Behavioral therapy, ongoing psychological support, and strong family support seem essential to improve long-term outcomes after LT and reduce the risk in relapse of alcohol use. […] Alcohol abstinence is the main prognostic factor associated with improved long-term survival, regardless of severity, and European and American guidelines recommend it as the first treatment strategy for alcohol-related liver disease.

• #56 Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation

  https://www.mdpi.com/2075-1729/13/9/1802

  Alcohol-related hepatitis (AH) is a clinical syndrome characterized by recent-onset jaundice in the context of alcohol consumption. […] According to European and American guidelines, liver transplantation (LT) may be considered in highly selected patients who do not respond to medical therapy. […] In conclusion, present data indicate that well-selected patients have excellent outcomes, with survival rates of up to 100% at 24 and 36 months after LT. Behavioral therapy, ongoing psychological support, and strong family support seem essential to improve long-term outcomes after LT and reduce the risk in relapse of alcohol use. […] Alcohol abstinence is the main prognostic factor associated with improved long-term survival, regardless of severity, and European and American guidelines recommend it as the first treatment strategy for alcohol-related liver disease.

• #57 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  The guideline also states that in patients with severe alcoholic hepatitis, 30-day survival may be improved by adding intravenous N-acetylcysteine (NAC) to prednisolone. […] Orthotopic liver transplantation is widely used in patients with end-stage liver disease. […] Patients with alcoholic hepatitis may be informed that their liver injury can be expected to subside, and liver function will improve following at least 6 months of abstinence. […] Adequate nutritional support is of paramount importance for the survival and recovery of patients with alcoholic hepatitis. […] In patients with alcoholic hepatitis who have developed cirrhosis, especially those with coexistent chronic viral hepatitis B or C, consider periodic surveillance for hepatocellular carcinoma. […] The 2019 American Association for the Study of Liver Diseases (AASLD) practice guidance recommends that all patients seen in primary care and gastroenterology/hepatology clinics, as well as all emergency department patients and hospital inpatients be screened for alcohol use using validated questionnaires.

• #58

  https://www.drugrehab.com/addiction/alcohol/effects-of-alcohol/hepatitis/

  Alcohol rehab is often required to help people who are addicted to alcohol stay sober. They have to quit drinking alcohol to recover from alcoholic hepatitis. […] In addition to abstinence, treatments for alcoholic hepatitis include: corticosteroid medications to reduce inflammation, pentoxifylline (Trental) to improve kidney function, nutritional support to reverse health problems caused by malnutrition. […] In severe cases, feeding tubes may be necessary to ensure a person receives proper nutrition because many patients with alcoholic hepatitis have low appetite. […] Other treatments that address complications associated with alcoholic hepatitis: ascites can be treated by reducing salt consumption in the diet and taking diuretic medications; hepatic encephalopathy may be treated with a medication called lactulose and antibiotics that remove toxins from the gut; kidney failure caused by a condition called hepatorenal syndrome may be treated with a medication called Albumin and drugs that constrict blood vessels, such as terlipressin, midodrine and octreotide, or norepinephrine.

• #59 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  Short-term steroids. Healthcare providers may treat certain severe cases of alcohol-induced hepatitis temporarily with steroids to help reduce inflammation and encourage liver cells to regenerate. […] If its not too far advanced, it can be reversed by quitting alcohol. Those who dont quit will continue to progress toward cirrhosis and liver failure. Existing scar tissue in your liver cant be reversed, but you can still prevent further damage and preserve the rest of your liver by quitting. […] People who quit drinking alcohol after diagnosis show great improvement after six to 12 months. Milder cases often resolve completely. More severe cases can continue to show gradual improvement over the following years. […] If you dont stop drinking after diagnosis, you have a reduced life expectancy. For men who dont stop drinking, the five-year survival rate is about 70%. For women who dont stop drinking, its 30%. People with severe alcohol-induced hepatitis and advanced liver disease have poorer outcomes. Up to 40% of people with severe alcohol-induced hepatitis die within six months of diagnosis.

• #60 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  Cessation of alcohol use is the mainstay of treatment for alcoholic hepatitis. The 2019 American Association for the Study of Liver Diseases (AASLD) alcoholic-associated liver disease guideline states that abstinence should be enjoined on patients with alcoholic hepatitis to improve long-term prognosis. […] In general, alcoholic hepatitis resolves or improves greatly following 6-12 months of alcohol abstinence, and continued improvement may be observed for several years. […] Some studies have suggested that improved energy and protein intake may improve the survival rate in patients with severe alcoholic hepatitis. […] However, according to the 2019 American Association for the Study of Liver Diseases (AASLD) alcohol-associated liver disease guidelines, in patients with severe alcoholic hepatitis (MDF of 32 or above) who have no contraindications to corticosteroid use, consideration should be given to the oral administration of prednisolone (40 mg/day) to improve 28-day mortality.

• #61 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  Short-term steroids. Healthcare providers may treat certain severe cases of alcohol-induced hepatitis temporarily with steroids to help reduce inflammation and encourage liver cells to regenerate. […] If its not too far advanced, it can be reversed by quitting alcohol. Those who dont quit will continue to progress toward cirrhosis and liver failure. Existing scar tissue in your liver cant be reversed, but you can still prevent further damage and preserve the rest of your liver by quitting. […] People who quit drinking alcohol after diagnosis show great improvement after six to 12 months. Milder cases often resolve completely. More severe cases can continue to show gradual improvement over the following years. […] If you dont stop drinking after diagnosis, you have a reduced life expectancy. For men who dont stop drinking, the five-year survival rate is about 70%. For women who dont stop drinking, its 30%. People with severe alcohol-induced hepatitis and advanced liver disease have poorer outcomes. Up to 40% of people with severe alcohol-induced hepatitis die within six months of diagnosis.

• #62 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  Alcoholic hepatitis (AH) is an acute hepatic manifestation occurring from heavy alcohol ingestion. Alcohol abstinence is the cornerstone of therapy for AH and, in the milder forms, is sufficient for clinical recovery. Severe ASH may progress to multi-organ failure including acute kidney injury and infection. Thus, infection and renal failure have a major impact on survival and should be closely monitored in patients with severe ASH. Patients with severe ASH have a reported short-term mortality of up to 40%-50%. Corticosteroids are the mainstay of treatment for severe ASH. When corticosteroids are contraindicated, pentoxifylline may be alternatively used. […] Alcohol abstinence is the linchpin of therapy for AH, since abstinence failure increases mortality rates among those with AH. However, anti-craving drugs such as disulfiram, naltrexone, and acamprosate are not routinely recommended to patients with severe AH due to the risk of potential hepatotoxicity.

• #63 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Both pentoxifylline and prednisolone are recommended for severe alcoholic hepatitis but long-term benefits remain questionable. […] Liver transplantation could be considered for patients not responsive to steroids and with a MELD of greater than 26. […] If the patient has acute renal failure, nephrology should be consulted to rule out hepatorenal syndrome. […] If the patient has a change in mental status, develops seizures or focal deficits, a neurologist should be consulted. […] Patients with alcoholic hepatitis need long-term follow-up. Many can benefit from attending AA or a similar abuse treatment program. […] The combination of systemic illness, malnutrition, concurrent renal injury, infections, lack of response to glucocorticoids or pentoxifylline result in poorer outcomes in severe alcoholic hepatitis.

• #64 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support

  https://emedicine.medscape.com/article/170539-treatment

  The guideline also states that in patients with severe alcoholic hepatitis, 30-day survival may be improved by adding intravenous N-acetylcysteine (NAC) to prednisolone. […] Orthotopic liver transplantation is widely used in patients with end-stage liver disease. […] Patients with alcoholic hepatitis may be informed that their liver injury can be expected to subside, and liver function will improve following at least 6 months of abstinence. […] Adequate nutritional support is of paramount importance for the survival and recovery of patients with alcoholic hepatitis. […] In patients with alcoholic hepatitis who have developed cirrhosis, especially those with coexistent chronic viral hepatitis B or C, consider periodic surveillance for hepatocellular carcinoma. […] The 2019 American Association for the Study of Liver Diseases (AASLD) practice guidance recommends that all patients seen in primary care and gastroenterology/hepatology clinics, as well as all emergency department patients and hospital inpatients be screened for alcohol use using validated questionnaires.

• #65 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Both pentoxifylline and prednisolone are recommended for severe alcoholic hepatitis but long-term benefits remain questionable. […] Liver transplantation could be considered for patients not responsive to steroids and with a MELD of greater than 26. […] If the patient has acute renal failure, nephrology should be consulted to rule out hepatorenal syndrome. […] If the patient has a change in mental status, develops seizures or focal deficits, a neurologist should be consulted. […] Patients with alcoholic hepatitis need long-term follow-up. Many can benefit from attending AA or a similar abuse treatment program. […] The combination of systemic illness, malnutrition, concurrent renal injury, infections, lack of response to glucocorticoids or pentoxifylline result in poorer outcomes in severe alcoholic hepatitis.

• #66 Medical management of severe acute alcoholic hepatitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/medical-management-of-severe-acute-alcoholic-hepatitis/

  Best practices for diagnosing and managing severe acute alcoholic hepatitis. […] 1. Abstinence from drinking alcohol is the cornerstone of treatment for alcohol hepatitis (AH). 2. Patients with jaundice and suspected AH should have cultures of blood, urine and ascites, if present, to determine the presence of bacterial infections regardless of whether they have fever. 3. Patients with AH who have jaundice should be admitted to the hospital to encourage abstinence, restore adequate nutrition and exclude serious infections. 4. Imaging of the liver is warranted as part of the evaluation, but caution should be used in administering iodinated contrast dye, as it increases the risk of acute kidney injury (AKI). 5. Patients with AH require a diet with 1-1.5 g protein and 30-40 kcal/kg body weight for adequate recovery. If the patient is unable to eat because of anorexia or altered mental status, a feeding tube should be considered for enteral feeding. Parenteral nutrition alone is inadequate. 6. Severity and prognosis of AH should be evaluated using Maddrey Discriminant Function (MDF), Model for End-Stage Liver Disease (MELD), age, bilirubin, international normalized ratio, and creatinine (ABIC), or Glasgow scoring systems. Current treatments are based on this assessment. 7. Presence of systemic inflammatory response syndrome (SIRS) on admission is associated with an increased risk of multi-organ failure (MOF) syndrome. Development of MOF, usually due to infections developing after initial diagnosis of AH, is associated with a very high mortality rate. 8. Nephrotoxic drugs, including diuretics, should be avoided or used sparingly in patients with AH, since AKI is an early manifestation of MOF. 9. Patients with MDF > 32 or MELD score > 20 without a contraindication to glucocorticoid, such as hepatitis B viral infection, tuberculosis, or other serious infectious diseases, may be treated with methylprednisolone 32 mg daily, but the appropriate duration of treatment remains a subject of controversy. Methylprednisolone does not improve survival beyond 28 days, and the benefits for < 28 days are modest. 10. Patients with a contraindication to glucocorticoids may be treated with pentoxifylline 400 mg three times daily with meals. Data regarding the efficacy are conflicting. 11. Patients with severe AH, particularly those with a MELD score > 26 with good insight into their alcohol use disorder and good social support should be referred for evaluation for liver transplantation, as the 90-day mortality rate is very high. 12. Patients with mild to moderate AH defined by a MELD score < 20 and MDF < 32 should be referred for abstinence counseling and prescribed a high protein diet supplemented with B vitamins and folic acid.

• #67 Alcoholic hepatitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/diagnosis-treatment/drc-20351394

  Treatment for alcoholic hepatitis involves quitting drinking as well as therapies to ease the symptoms of liver damage. […] If you’ve been diagnosed with alcoholic hepatitis, you need to stop drinking alcohol and never drink alcohol again. It’s the only way that might reverse liver damage or keep the disease from getting worse. People who don’t stop drinking are likely to have some life-threatening health problems. […] Treatment might include: Medicines. Counseling. Alcoholics Anonymous or other support groups. Outpatient or live-in treatment program. […] Your healthcare professional might suggest a special diet to fix poor nutrition. […] These might help severe alcoholic hepatitis: Corticosteroids. These medicines might help some people with severe alcoholic hepatitis live longer. However, corticosteroids have serious side effects. They’re not likely to be used if you have failing kidneys, stomach bleeding or an infection.

• #68 Treatment of Severe Alcoholic Hepatitis

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5828019/

  In summary, pentoxifylline appears to increase survival compared with no treatment, but does not increase survival compared with prednisolone. […] NAC (usually given in combination with other oral antioxidants) does not appear to increase survival compared with standard medical therapy. However, the combination of NAC and prednisolone increased 1-month survival, and reduced infections and hepatorenal syndrome, compared with prednisolone alone. […] G-CSF might increase survival of patients with AH. G-CSF is easy to administer and has few adverse effects. However, additional studies should be performed in the West, and G-CSF should be tested in combination with prednisolone before it can be recommended as a treatment for AH. […] The application of these findings therefore requires consideration of each case individually, based on clinical, patient, and physician factors. Finally, no regimen increased the proportion of patients surviving until 6 months.

• #69 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Both pentoxifylline and prednisolone are recommended for severe alcoholic hepatitis but long-term benefits remain questionable. […] Liver transplantation could be considered for patients not responsive to steroids and with a MELD of greater than 26. […] If the patient has acute renal failure, nephrology should be consulted to rule out hepatorenal syndrome. […] If the patient has a change in mental status, develops seizures or focal deficits, a neurologist should be consulted. […] Patients with alcoholic hepatitis need long-term follow-up. Many can benefit from attending AA or a similar abuse treatment program. […] The combination of systemic illness, malnutrition, concurrent renal injury, infections, lack of response to glucocorticoids or pentoxifylline result in poorer outcomes in severe alcoholic hepatitis.

• #70 Severe alcoholic hepatitis: current perspectives | HMER

  https://www.dovepress.com/severe-alcoholic-hepatitis-current-perspectives-peer-reviewed-fulltext-article-HMER

  This meant that early liver transplantation could improve survival in a highly selected group of patients with the first episode of severe AH. […] Currently, evaluation of novel and combined therapies for severe AH are ongoing, featuring trials ranging from phase II to IV. […] Future studies on FMT in AH could improve on the current protocol, identify better methods for fecal transfer, utilize specific groups of bacterial species for targeted therapy or identify specific metabolites to modify through gut bacterial modulation in the form of precision metagenomic medicine. […] Severe alcoholic hepatitis is a catastrophic disease without approved therapy.

• #71 New treatment options for alcoholic hepatitis

  https://www.wjgnet.com/1007-9327/full/v22/i15/3892.htm

  There is a need to define and form guidelines for setting universally suitable and logically acceptable norms to do liver transplant in this group of patients which should also address delicate issues like pre transplantation counseling, deceased vs living related donor liver transplantation, setting up of Alcohology units for post transplant support systems etc. […] A major improvement in our understanding and a paradigm shift in the treatment approaches are required to improve the outcome of these patients.

Zobacz więcej